Drug Topics July 18, 2024
Brian Nowosielski

Emporos announced a strategic partnership with InterLink AI to help pharmacists streamline tasks and fill more prescriptions.

Combining a point of sale (POS) system with scripClip’s lighted pharmacy will-call system, the newly announced partnership between Emporos and InterLink AI will allow pharmacists to streamline tasks, free up their time around the pharmacy, and—crucially— improve patient care with swift yet valued care and services.

“Our partnership with Emporos reinforces the vision we share: to make the pharmacy experience more efficient and safer, for the health of pharmacies and their patients everywhere,” said Dan Gordon, InterLink AI President and CEO.1 “We are thrilled to provide a solution that maximizes operational efficiency at the point of sale.”

InterLink AI is the creator of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Partnerships, Pharma, Pharma / Biotech, Technology, Trends
Closing the women’s health gap: Biopharma’s untapped opportunity
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions

Share This Article